Notch signalling is a central regulator of differentiation in a variety of organisms and tissue types1. Its activity is controlled by the multi-subunit γ-secretase (γSE) complex2. Although Notch signalling can play both oncogenic and tumour-suppressor roles in solid tumours, in the haematopoietic system it is exclusively oncogenic, notably in T-cell acute lymphoblastic leukaemia, a disease characterized by Notch1-activating mutations3. Here we identify novel somatic-inactivating Notch pathway mutations in a fraction of patients with chronic myelomonocytic leukaemia (CMML). Inactivation of Notch signalling in mouse haematopoietic stem cells (HSCs) results in an aberrant accumulation of granulocyte/monocyte progenitors (GMPs), extramedullary haematopoieisis and the induction of CMML-like disease. Transcriptome analysis revealed that Notch signalling regulates an extensive myelomonocytic-specific gene signature, through the direct suppression of gene transcription by the Notch target Hes1. Our studies identify a novel role for Notch signalling during early haematopoietic stem cell differentiation and suggest that the Notch pathway can play both tumour-promoting and -suppressive roles within the same tissue.
At a glance
- Crossing paths with Notch in the hyper-network. Curr. Opin. Cell Biol. 19, 166–175 (2007) , , &
- Nicastrin: gatekeeper of the γ-secretase complex. Cell 122, 318–320 (2005)
- Molecular pathogenesis of T-cell leukaemia and lymphoma. Nature Rev. Immunol. 8, 380–390 (2008) , &
- Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1. EMBO J 27, 1886–1895 (2008) et al.
- T-cell development made simple. Nature Rev. Immunol. 4, 67–72 (2004)
- Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601–649 (2005) &
- Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nature Rev. Cancer 6, 1–13 (2006) , &
- Inducible gene targeting in mice. Science 269, 1427–1429 (1995) , , &
- Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development 132, 203–213 (2005) &
- Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Leukemia 22, 1335–1342 (2008)
- Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1. Cell Stem Cell 6, 265–278 (2010) , , &
- Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30, 493–507 (2009) , , &
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818–822 (2006) et al.
- Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of notch signaling in the murine skin. PLoS ONE 5, e9258 (2010) et al.
- Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547–558 (1999) et al.
- Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol 6, e123 (2008) et al.
- CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 459, 1000–1004 (2009) et al.
- JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 15, 341–352 (2009) et al.
- Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 3, 314–326 (2008) et al.
- Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965–978 (2005) , , &
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24, 1128–1138 (2010)
- Early T cell receptor β gene expression is regulated by the pre-T cell receptor-CD3 complex. J. Exp. Med. 190, 141–144 (1999) , , , &
- Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev. Biol. 269, 81–94 (2004) et al.
- Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675–685 (2003) et al.
- Functional analysis of secreted and transmembrane proteins critical to mouse development. Nature Genet. 28, 241–249 (2001) et al.
- Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410, 174–179 (2001) et al.
- High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nature Genet. 25, 139–140 10.1038/75973. (2000) et al.
- Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205, 1395–1408 (2008) et al.
- Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005) et al.
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267–273 (2003) et al.
- An early decrease in Notch activation is required for human TCR-αβ lineage differentiation at the expense of TCR-γδ T cells. Blood 113, 2988–2998 (2009) et al.
- Notch signaling is required for proliferation but not for differentiation at a well-defined β-selection checkpoint during human T-cell development. Blood 113, 3254–3263 (2009) et al.
- Supplementary Information (15.1M)
This file contains Supplementary Figure 1-16 with legends and Supplementary Tables 1-5.